Literature DB >> 15184329

The headache of teenage acne.

Tania Cellucci1, Liesly Lee, David N Juurlink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184329      PMCID: PMC419762          DOI: 10.1503/cmaj.1031950

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Asymptomatic intracranial hypertension associated with tetracycline use.

Authors:  E Bonioli; C Bellini; A Di Stefano
Journal:  Pediatr Infect Dis J       Date:  1999-09       Impact factor: 2.129

Review 2.  Diagnostic criteria for idiopathic intracranial hypertension.

Authors:  Deborah I Friedman; Daniel M Jacobson
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

3.  Pseudotumour cerebri: risk for cognitive impairment?

Authors:  C P Kaplan; M E Miner; J M McGregor
Journal:  Brain Inj       Date:  1997-04       Impact factor: 2.311

Review 4.  Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases.

Authors:  A Kesler; Y Goldhammer; N Gadoth
Journal:  J Neuroophthalmol       Date:  2001-03       Impact factor: 3.042

5.  Minocycline treatment and pseudotumor cerebri syndrome.

Authors:  A M Chiu; W L Chuenkongkaew; W T Cornblath; J D Trobe; K B Digre; S A Dotan; K H Musson; E R Eggenberger
Journal:  Am J Ophthalmol       Date:  1998-07       Impact factor: 5.258

6.  Assessment of visual function in idiopathic intracranial hypertension: a prospective study.

Authors:  F J Rowe; N J Sarkies
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

7.  The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)

Authors:  L N Johnson; G B Krohel; R W Madsen; G A March
Journal:  Ophthalmology       Date:  1998-12       Impact factor: 12.079

8.  Idiopathic intracranial hypertension in the pediatric population.

Authors:  Anat Kesler; Aviva Fattal-Valevski
Journal:  J Child Neurol       Date:  2002-10       Impact factor: 1.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.